Mirae Asset Global Investments Co., Ltd. Pacira Bio Sciences, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$24 Billion
Q4 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,539 shares of PCRX stock, worth $37,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,539

Previous 1,668 7.73%

Holding current value

$37,936

Previous $25,000 12.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$15.3 - $20.33 $1,973 - $2,622	-129 Reduced 7.73%	1,539 $28,000
Q3 2024 Oct 23, 2024	BUY	$11.7 - $28.46 $3,252 - $7,911	278 Added 20.0%	1,668 $25,000
Q2 2024 Jul 30, 2024	SELL	$25.5 - $31.51 $502,018 - $620,337	-19,687 Reduced 93.41%	1,390 $39,000
Q1 2024 May 01, 2024	SELL	$27.7 - $35.48 $24,819 - $31,790	-896 Reduced 4.08%	21,077 $615,000
Q4 2023 Jan 24, 2024	BUY	$26.32 - $34.31 $31,215 - $40,691	1,186 Added 5.71%	21,973 $741,000
Q3 2023 Oct 26, 2023	BUY	$30.68 - $40.09 $1,534 - $2,004	50 Added 0.24%	20,787 $637,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $47.5 $3,359 - $4,417	-93 Reduced 0.45%	20,737 $830,000
Q1 2023 May 04, 2023	SELL	$35.53 - $43.38 $994 - $1,214	-28 Reduced 0.13%	20,830 $850,000
Q4 2022 Feb 09, 2023	BUY	$38.19 - $57.45 $33,530 - $50,441	878 Added 4.39%	20,858 $805,000
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $295,398 - $339,500	5,765 Added 40.56%	19,980 $1.06 Million
Q2 2022 Jul 26, 2022	BUY	$51.49 - $81.64 $731,930 - $1.16 Million	14,215 New	14,215 $829,000
Q1 2018 May 10, 2018	SELL	$29.98 - $46.35 $1.14 Million - $1.76 Million	-37,895 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$31.85 - $46.95 $1.21 Million - $1.78 Million	37,895	37,895 $1.73 Million

Others Institutions Holding PCRX

# of Institutions

258

Shares Held

49.4M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.13B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Pacira Bio Sciences, Inc. Transaction History